Mark Andrew Kroenke

Title: Mark Andrew Kroenke: Innovator in Celiac Disease Treatment

Introduction

Mark Andrew Kroenke is a notable inventor based in Newbury Park, California. He has made significant contributions to the field of medical treatments, particularly focusing on celiac disease. With a total of 2 patents, his work is paving the way for innovative therapeutic solutions.

Latest Patents

Kroenke's latest patents revolve around the treatment of celiac disease using immunoglobulin A (IgA). The process involves administering monoclonal or polyclonal IgA in various forms, including monomeric, dimeric, or polymeric. By joining a secretory component to the IgA, the degradation during oral administration is limited. The formulation can be mixed with agents to create dosing forms such as capsules, tablets, or suppositories. Additionally, the therapeutic can be enrobed through microencapsulation or coated with an enteric coating for enhanced efficacy.

Career Highlights

Throughout his career, Kroenke has focused on developing innovative treatments that address unmet medical needs. His dedication to research and development has led to advancements in therapeutic options for patients suffering from celiac disease. His work exemplifies the intersection of science and practical application in medicine.

Collaborations

Kroenke collaborates with various professionals in the field, including his coworker Michael Richard Simon. Their combined expertise contributes to the development of effective treatments and enhances the potential for future innovations.

Conclusion

Mark Andrew Kroenke's contributions to the treatment of celiac disease highlight his role as an influential inventor in the medical field. His innovative approaches and dedication to improving patient outcomes are commendable.